Technology-assisted locomotion therapy in people with residual gait impairment after a neurological event

Phase 4

Recruiting

• Conditions: S14; I63.9; Cerebral infarction, unspecified; Injury of nerves and spinal cord at neck level

• Registration Number: DRKS00022766
• Lead Sponsor: ZHAW

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Residual gait impairment after neurological event, medical clearance for technology-based gait training, good communication skills in German, subscription to Revigo for duration of study participation (with financial contribution from insurance and Revigo), signed informed written consent

Exclusion Criteria

ongoing in-patient rehabilitation, neuro-psychological impairments, including cognitive deficits, that make communication and cooperation impossible, diagnosis of multiple sclerosis or Parkinson’s disease, pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective of this study is to determine if a three months technology-based gait training will lead to functional improvements (determined using 10 MWT). The 10 MWT will be assessed at baseline, after 3 months and for some participants also after 6 months.

Secondary Outcome Measures

Name	Time	Method
relevant improvements in gait ability.<br>As secondary objective, the amount of performed trainings, general health (including quality of life), as well as costs associated with the training will be assessed. The following assessments will be used: PGIC, FAC, TUG, L-Force-TEst, WHODAS, EQ-5D, amount of trainings, willingness to pay, costs. The assessments will be assessed at baseline, after 3 months and for some participants also after 6 months.